An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection
Condition: Influenza, Human Intervention: Drug: Zanamivir Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 31, 2020 Category: Research Source Type: clinical trials
Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults
Condition: Influenza, HumanIntervention: Drug: ZanamivirSponsor: GlaxoSmithKlineNot yet recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2015 Category: Research Source Type: clinical trials
Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults
Condition: Influenza, HumanIntervention: Drug: ZanamivirSponsor: GlaxoSmithKlineNot yet recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2015 Category: Research Source Type: clinical trials
Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults
Condition: Influenza, HumanIntervention: Drug: ZanamivirSponsor: GlaxoSmithKlineRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2015 Category: Research Source Type: clinical trials
A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection
Condition: Influenza, HumanIntervention: Drug: Intravenous (IV) zanamivirSponsors: GlaxoSmithKline; GlaxoSmithKlineRecruiting - verified October 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2011 Category: Research Source Type: clinical trials
